Cited by 335Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

Tang, Thomas, Glanville, Julie, Hayden, Catherine J., White, Davinia, Barth, Julian H., Balen, Adam H.·2006·Human Reproduction

Abstract

Background It has been reported that women with polycystic ovary syndrome (PCOS) benefit from metformin therapy. Methods A randomized, placebo-controlled, double-blind study of obese (body mass index >30 kg/m2), oligo-/amenorrhoeic women with PCOS. Metformin (850 mg) twice daily was compared with placebo over 6 months. All received the same advice from a dietitian. The primary outcome measures were: (i) change in menstrual cycle; (ii) change in arthropometric measurements; and (iii) changes in the endocrine parameters, insulin sensitivity and lipid profile. Results A total of 143 subjects was randomized [metformin (MET) = 69; placebo (PL) = 74]. Both groups showed significant improvements in menstrual frequency [median increase (MET = 1, P Conclusions Metformin does not improve weight loss or menstrual frequency in obese patients with PCOS. Weight loss alone through lifestyle changes improves menstrual frequency.

Integrity signals

Registry

Crossref · 10.1093/humrep/dei311

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Tang et al. (2006), pregnancy rates were 8.7% (6/69) on lifestyle plus metformin and 2.7% (2/74) on lifestyle plus placebo, with no significant difference.

    “In another study with participants who all desired pregnancy, pregnancy rates were 8.7% (6/69) on lifestyle + metformin and 2.7% (2/74) on lifestyle + placebo, with no significant difference (Tang et al. , 2006).”
  • The remaining four studies did not report significant differences in menstruation between groups (Tang et al., 2006; Karimzadeh and Javedani, 2010; Ladson et al., 2011a, b).

    “The remaining four studies did not report significant differences in menstruation betweengroups (Tang et al. , 2006; Karimzadeh and Javedani, 2010; Ladson et al. , 2011a, b).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tang, T., Glanville, J., Hayden, C. J., White, D., Barth, J. H., & Balen, A. H.
Affiliations
Leeds General Infirmary (GB)
Corresponding author
Tang, Thomas
Venue
Human Reproduction
Published
2005-09-30
Volume
21
Issue
1
Pages
80-89
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2137832653
Cited by
335
References
10
Citations by year
2026: 4 · 2025: 9 · 2024: 5 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 18 · 2019: 12 · 2018: 12 · 2017: 18 · 2016: 14 · 2015: 20 · 2014: 17 · 2013: 17 · 2012: 16
FWCI
24.88
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, metformin, obesity, lifestyle modification, weight loss, menstrual frequency, insulin sensitivity, lipid profile, free androgen index, waist circumference
MeSH terms
Adult, Anthropometry, Double-Blind Method, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Life Style, Lipids, Menstruation, Metformin, Obesity, Polycystic Ovary Syndrome, Pregnancy, Weight Loss, Treatment Outcome, Pregnancy Rate, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review